Skip to content

Using advanced MRI sequence to distinguish between cancer and radiation induced damage in treated brain tumors like Glioma

DIFFERENTIATING TUMOR RECURRENCE FROM RADIATION NECROSIS IN TREATED CASES OF GRADE 3 AND 4 GLIOMAS USING ARTERIAL SPIN LABELING MAGNETIC RESONANCE IMAGING - -

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064109
Enrollment
252
Registered
2024-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C71- Malignant neoplasm of brain

Interventions

Control Intervention1: NA: NA

Sponsors

Dr ARPITA SAHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with histologically proven higher grade gliomas who underwent treatment (chemotherapy, radiotherapy or both) and having suspicion for tumor recurrence or radiation necrosis.

Exclusion criteria

Exclusion criteria: 1. Patients with non-glial tumors on histology. 2. Patients who do not have tissue diagnosis or are lost on imaging follow up.

Design outcomes

Primary

MeasureTime frame
1.To assess the utility of Arterial Spin Labeling (ASL) in brain tumor protocol for distinguishing tumor recurrence from radiation necrosis in treated cases of grade 3 and 4 gliomas.Timepoint: Project time is 3 years.

Secondary

MeasureTime frame
1. To compare findings of perfusion i.e.Arterial Spin Labeling (ASL) and Dynamic Susceptibility Contrast (DSC) MRI. 2. Quantitative analysis of ASL, DSC findings. 3. Qualitative analysis of ASL and DSC perfusion maps. 4. To assess anyaltered signal by other MR sequences – T1W, T2W, T1 FLAIR, Post contrast T1, Post contrast T2 FLAIR, Diffusion weighted imaging, Spectroscopy. 5. Comparison of MRI results with amino acids.Timepoint: Project time is 3 years.

Countries

India

Contacts

Public ContactDr SATISH KUMAR MAHAPATRA

TATA MEMORIAL HOSPITAL, MUMBAI

drarpitasahu@gmail.com2269537300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026